Biora Therapeutics Biora Therapeutics (formerly known as Ascendant Mdx and Progenity) is a biotech company that provides reimagining therapeutic services. | ![]() Natera Natera (formerly known as Gene Security Network) is a diagnostics company with proprietary molecular and bioinformatics technology. | |||||
Founding Date | Founding Date 2010 | Founding Date 2000 | Founding Date 1999 | Founding Date 2004 | Founding Date 1991 | Founding Date 2010 |
Type | Type Public | Type Subsidiary | Type Subsidiary | Type Public | Type Public | Type Subsidiary |
Tags | ||||||
Locations | Locations San Diego, US HQ San Diego, US | Locations Gaithersburg, US HQ | Locations Aliso Viejo, US HQ Aliso Viejo, US | Locations Austin, US HQ San Carlos, US | Locations Salt Lake City, US HQ Paris, FR Munich, DE Tokyo, JP Amsterdam, NL Zürich, CH | Locations San Francisco, US HQ |
Employees | Employees 5456% decrease | Employees 8964% increase | Employees 9094% increase | Employees 3,28211% increase | Employees 2,700 | Employees 8601% decrease |
Valuation ($) | Valuation ($) 16.4 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 15.4 b | Valuation ($) 2 b | Valuation ($) N/A |
Financial | ||||||
Revenue (est.) | Revenue (est.) $4k (FY, 2023) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $2.3b (FY, 2025) | Revenue (est.) $824.5m (FY, 2025) | Revenue (est.) $516.3m (FY, 2022) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods $247.9m (FY, 2025) | Cost of goods $417.3m (FY, 2022) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit $576.6m (FY, 2025) | Gross profit $99m (FY, 2022) |
Net income | Net income ($124.1m) (FY, 2023) | Net income N/A | Net income N/A | Net income ($208.2m) (FY, 2025) | Net income ($365.9m) (FY, 2025) | Net income ($3.1b) (FY, 2022) |
Operating ⚠ | ||||||
Facilities Leased, sq. ft. | Facilities Leased, sq. ft. N/A | Facilities Leased, sq. ft. N/A | Facilities Leased, sq. ft. N/A | Facilities Leased, sq. ft. 272 k (FY, 2021) | Facilities Leased, sq. ft. 500.1 k (FY, 2022) | Facilities Leased, sq. ft. N/A |
Tests | Tests N/A | Tests 561 (Oct, 2022) | Tests N/A | Tests 489.3 k (Q1, 2022) | Tests N/A | Tests N/A |
Trademarks (US) | Trademarks (US) N/A | Trademarks (US) 8 (Oct, 2022) | Trademarks (US) 65 (Aug, 2022) | Trademarks (US) N/A | Trademarks (US) N/A | Trademarks (US) N/A |
Funding | ||||||
Total funding raised | Total funding raised $ 138.5m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 154.1m | Total funding raised N/A | Total funding raised $ 363.1m |

GeneDx is a company operating in the genetics and genomics industry.
View company
Ambry Genetics is a company that provides genetic testing solutions.
View company
Natera (formerly known as Gene Security Network) is a diagnostics company with proprietary molecular and bioinformatics technology.
View companyMyriad Genetics is a company that develops and offers genetic tests.
View company